Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2

C D Loftin, D B Trivedi, H F Tiano, J A Clark, C A Lee, J A Epstein, S G Morham, M D Breyer, M Nguyen, B M Hawkins, J L Goulet, O Smithies, B H Koller, R Langenbach, C D Loftin, D B Trivedi, H F Tiano, J A Clark, C A Lee, J A Epstein, S G Morham, M D Breyer, M Nguyen, B M Hawkins, J L Goulet, O Smithies, B H Koller, R Langenbach

Abstract

The transition to pulmonary respiration following birth requires rapid alterations in the structure of the mammalian cardiovascular system. One dramatic change that occurs is the closure and remodeling of the ductus arteriosus (DA), an arterial connection in the fetus that directs blood flow away from the pulmonary circulation. A role for prostaglandins in regulating the closure of this vessel has been supported by pharmacological and genetic studies. The production of prostaglandins is dependent on two cyclooxygenases (COX-1 and COX-2), which are encoded by separate genes. We report here that the absence of either or both COX isoforms in mice does not result in premature closure of the DA in utero. However, 35% of COX-2(-/-) mice die with a patent DA within 48 h of birth. In contrast, the absence of only the COX-1 isoform does not affect closure of the DA. The mortality (35%) and patent DA incidence due to absence of COX-2 is, however, significantly increased (79%) when one copy of the gene encoding COX-1 is also inactivated. Furthermore, 100% of the mice deficient in both isoforms die with a patent DA within 12 h of birth, indicating that in COX-2-deficient mice, the contribution of COX-1 to DA closure is gene dosage-dependent. Together, these data establish roles for COX-1, and especially for COX-2, in the transition of the cardiopulmonary circulation at birth.

Figures

Figure 1
Figure 1
COX-dependent DA closure in neonatal mice. The DA was analyzed in pups 5 h after birth. (A) COX-1(+/+)/COX-2(+/+). (B) COX-1(−/−)/COX-2(−/−). (C) COX-1(+/−)/COX-2(−/−). (D) COX-1(+/−)/COX-2(−/−). (E) COX-1(+/−)/COX-2(−/−). (F) COX-1(−/−)/COX-2(+/−). Ao, aorta. (Scale bar, 100 μm.) Genotype figure labels, Ptgs1 genotype/Ptgs2 genotype.
Figure 2
Figure 2
COX-2-dependent DA closure after maternal indomethacin treatment. Histological sections are from fetal DA on gestation day 18.5. (A) COX-1(+/+)/COX-2(+/+). (B) COX-1(+/−)/COX-2(+/−). (C) COX-1(−/−)/COX-2(+/−). (D) COX-1(+/+)/COX-2(−/−). (E) COX-1(+/−)/COX-2(−/−). (F) COX-1(−/−)/COX-2(−/−). Ao, aorta. (Scale bar, 100 μm.) Genotype figure labels, Ptgs1 genotype/Ptgs2 genotype.
Figure 3
Figure 3
Immunohistochemical analysis of COX-1 and COX-2. DA sections obtained from neonates sacrificed 2.5 h after birth. (A) COX-1(+/+)/COX-2(+/+), anti-COX-2; (Inset) perinuclear staining. (B) COX-1(+/+)/COX-2(−/−), anti-COX-2. (C) COX-1(+/+)/COX-2(+/+), anti-COX-1; (Inset) epidermis of COX-1(+/+)/COX-2(+/+), anti-COX-1. (Scale bar, 100 μm.) Genotype figure labels, Ptgs1 genotype/Ptgs2 genotype.

Source: PubMed

3
Abonneren